Quantitative assessment of caveolin-1 G14713A polymorphism and cancer susceptibility in the Asian population
Authors Tang J, Wang G, Li Q, Song R
Received 20 July 2015
Accepted for publication 14 October 2015
Published 10 March 2016 Volume 2016:9 Pages 1381—1387
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Ram Prasad
Peer reviewer comments 4
Editor who approved publication: Professor Daniele Santini
Jianjun Tang,1,* Gang Wang,2,* Qiang Li,1 Rongfeng Song1
1Department of Gastroenterology, Cancer Hospital of Jiangxi Province, Nanchang, Jiangxi, 2State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of China
*These authors contributed equally to this work
Purpose: The relationship between caveolin-1 (CAV1) G14713A polymorphism and cancer susceptibility remains inconclusive. The current meta-analysis was performed on the basis of a systematic search in electronic databases for a more precise estimation of the associations.
Methods: Odds ratio (OR) with 95% confidence interval (CI) was used to estimate the pooled effect.
Results: A total of 12 studies including 4,994 cases and 5,606 controls were involved in this meta-analysis. In the overall analysis, CAV1 G14713A polymorphism was significantly associated with an increased risk of cancer (A vs G: OR =1.77, 95% CI: 1.49–2.10, Phet<0.01; [AA + AG] vs GG: OR =2.03, 95% CI: 1.64–2.53, Phet<0.01; AA vs [AG + GG]: OR =1.72, 95% CI: 1.40–2.12, Phet<0.01; AA vs GG: OR =2.24, 95% CI: 1.69–2.98, Phet<0.01; AG vs GG: OR =1.98, 95% CI: 1.62–2.41, Phet<0.01). Subgroup analysis by cancer type showed that CAV1 G14713A polymorphism was associated with an increased risk of digestive system cancer and other cancer types.
Conclusion: Our findings suggest that CAV1 G14713A polymorphisms may modify the risk of cancer, especially digestive system cancer. However, further well-designed studies are warranted to validate this association.
Keywords: caveolin-1, polymorphism, cancer, susceptibility
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]